138 related articles for article (PubMed ID: 37414194)
1. SOX9 Expression Pattern and Its Prognosis in Gastric Cancer Should be Fully Evaluated.
Li G; Chen H; Ren C
Gastroenterology; 2023 Oct; 165(4):1094. PubMed ID: 37414194
[No Abstract] [Full Text] [Related]
2. Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
Zhang N; Chai D; Du H; Li K; Xie W; Li X; Yang R; Lian X; Xu Y
BMC Cancer; 2018 Mar; 18(1):344. PubMed ID: 29587675
[TBL] [Abstract][Full Text] [Related]
3. Expression and Clinical Relevance of SOX9 in Gastric Cancer.
Mesquita P; Freire AF; Lopes N; Gomes R; Azevedo D; Barros R; Pereira B; Cavadas B; Pópulo H; Boaventura P; David L; Pereira L; Almeida R
Dis Markers; 2019; 2019():8267021. PubMed ID: 31275454
[TBL] [Abstract][Full Text] [Related]
4. MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9.
Shang JC; Yu GZ; Ji ZW; Wang XQ; Xia L
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6160-6169. PubMed ID: 31364116
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA SNHG14 contributes to gastric cancer development through targeting miR-145/SOX9 axis.
Liu Z; Yan Y; Cao S; Chen Y
J Cell Biochem; 2018 Aug; 119(8):6905-6913. PubMed ID: 29667771
[TBL] [Abstract][Full Text] [Related]
6. SOX9 is expressed in normal stomach, intestinal metaplasia, and gastric carcinoma in humans.
Sashikawa Kimura M; Mutoh H; Sugano K
J Gastroenterol; 2011 Nov; 46(11):1292-9. PubMed ID: 21861142
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-520f-3p inhibits proliferation of gastric cancer cells via targeting SOX9 and thereby inactivating Wnt signaling.
Chen JQ; Huang ZP; Li HF; Ou YL; Huo F; Hu LK
Sci Rep; 2020 Apr; 10(1):6197. PubMed ID: 32277152
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers.
Choi YJ; Song JH; Yoon JH; Choi WS; Nam SW; Lee JY; Park WS
Gastric Cancer; 2014 Apr; 17(2):247-54. PubMed ID: 23812904
[TBL] [Abstract][Full Text] [Related]
9. Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer.
Link H; Angele M; Schüller M; Ganschow P; Machetanz L; Guba M; Werner J; Kirchner T; Neumann J
BMC Cancer; 2018 Apr; 18(1):483. PubMed ID: 29703178
[TBL] [Abstract][Full Text] [Related]
10. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
[TBL] [Abstract][Full Text] [Related]
11. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M
PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
[TBL] [Abstract][Full Text] [Related]
12. Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma.
Luo W; Nagaria TS; Sun H; Ma J; Lombardo JL; Bassett R; Cao AC; Tan D
Pathol Oncol Res; 2022; 28():1610293. PubMed ID: 35221802
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic relevance of SOX9 stem cell factor in gastric cancer.
Carrasco-Garcia E; Álvarez-Satta M; García-Puga M; Ribeiro ML; Arevalo S; Arauzo-Bravo M; Matheu A
Expert Opin Ther Targets; 2019 Feb; 23(2):143-152. PubMed ID: 30572738
[TBL] [Abstract][Full Text] [Related]
14. PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression.
Song S; Wang Z; Li Y; Ma L; Jin J; Scott AW; Xu Y; Estrella JS; Song Y; Liu B; Johnson RL; Ajani JA
Mol Cancer Res; 2020 Mar; 18(3):390-402. PubMed ID: 31796534
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA
Zhao H; Xiao H; Lu Y; Liu S; Wang C
Cell Cycle; 2020 May; 19(10):1143-1157. PubMed ID: 32308105
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
[TBL] [Abstract][Full Text] [Related]
17. SOX9 expression and its methylation status in gastric cancer.
Sun M; Uozaki H; Hino R; Kunita A; Shinozaki A; Ushiku T; Hibiya T; Takeshita K; Isogai M; Takada K; Fukayama M
Virchows Arch; 2012 Mar; 460(3):271-9. PubMed ID: 22331131
[TBL] [Abstract][Full Text] [Related]
18. The dose-dependent effect of SOX9 and its incidence in colorectal cancer.
Prévostel C; Blache P
Eur J Cancer; 2017 Nov; 86():150-157. PubMed ID: 28988015
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
20. LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability.
Song H; Xu Y; Shi L; Xu T; Fan R; Cao M; Xu W; Song J
Biomed Pharmacother; 2018 Dec; 108():338-346. PubMed ID: 30227327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
